ADIM
WBT

Alpha DNA Investment Management’s Welbilt, Inc. WBT Stock Holding History

Alpha DNA Investment Management’s Portfolio WBT Stock Details WBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-187
Closed -$3K – 733
2021
Q1 		$3K Buy
+187
New +$2.81K ﹤0.01% 541

Other funds holding WBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Alpha DNA Investment Management's WBT Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Welbilt, Inc. (WBT) in Q2 2021, closing a stake of 187 shares — an estimated $3K sold.

Alpha DNA Investment Management first reported a position in WBT in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 233 funds tracked by Wall St. Rank hold WBT as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Welbilt, Inc. position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 187 Welbilt, Inc. shares in Q2 2021, an estimated $3K.
  • Alpha DNA Investment Management first reported a position in Welbilt, Inc. in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Welbilt, Inc. position peaked at $3K in Q1 2021.
  • 233 funds tracked by Wall St. Rank held Welbilt, Inc. as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.